scholarly journals Relationship of Biological Markers of Body Fat Distribution and Corticosteroidogenic Enzyme Activities in Women with Polycystic Ovary Syndrome

2019 ◽  
Vol 51 (10) ◽  
pp. 639-648
Author(s):  
Sebastião Freitas de Medeiros ◽  
Matheus Antonio Souto de Medeiros ◽  
Bruna Barcelo Barbosa ◽  
Márcia Marly Winck Yamamoto

AbstractThe aim of the study is to determine the impact of different anthropometric measurements of fat distribution on baseline sex-steroid concentrations and corticosteroidogenic enzyme activity in women with polycystic ovary syndrome compared to those with regular menstrual cycles. The current cross-sectional study included 106 normal cycling controls and 268 polycystic ovary syndrome patients. Patients with polycystic ovary syndrome, diagnosed by Rotterdam criteria, were divided in normoandrogenemic (n=91) and hyperandrogenemic (n=177). Anthropometric, biochemical, and hormone parameters were assessed and correlated with corticosteroidogenic enzyme activities in all three groups. Corticosteroidogenic enzyme activities were calculated using product-to-precursor ratios. Regarding sex-steroids individually, anthropometric parameters correlated with the concentrations of several androgens in polycystic ovary syndrome patients, most of them in patients with biochemical hyperandrogenism. The androgen precursors androstenedione, 17-hydroxyprogesterone, and dehydroepiandrosterone were less correlated with anthropometric parameters. The 17,20 lyase activity, in both Δ4 and Δ5 pathways, correlated with several anthropometric measurements in normo- and hyperandrogenemic polycystic ovary syndrome patients. The 17,20 lyase enzyme activity (Δ4 pathway) also correlated with conicity index, visceral adiposity index, and lipid accumulation product in the control group. 17-Hydroxylase activity positively correlated with waist-height ratio in both polycystic ovary syndrome groups. In contrast, 17-hydroxilase negatively correlated with the conicity index. Anthropometric markers of adiposity are associated with androgen levels and their precursors in blood. Body fat distribution correlates with the activities of some steroidogenic enzyme in both normo-and hyperandrogenemic polycystic ovary syndrome phenotypes. The molecular mechanisms involved in these associations are largely unclear and more investigations are required.

2013 ◽  
Vol 20 (2) ◽  
pp. 107-115
Author(s):  
Cristian-Ioan Iuhas ◽  
Nicolae Costin ◽  
Cristina Niţă ◽  
Dan Mihu

AbstractBackground and Aims. Most women with Polycystic Ovary Syndrome (PCOS) are thought to have an abdominal body fat distribution, regardless of body mass index (BMI). The objective of our research was to compare body fat distribution between PCOS cases and BMI/age matched healthy control women. Materials and Methods. We compared 102 women with PCOS and 120 healthy female patients matched for age and BMI (retrospective review of the medical records). Visceral fat area (VFA) was measured by bioelectric impedance. Results. No significant differences were noted between the PCOS group and controls regarding total cholesterol, LDLcholesterol and triglycerides levels. Mean HDL-cholesterol concentration was significantly lower in the PCOS group (p=0.03). Mean fasting serum insulin and calculated HOMA-IR were higher in the PCOS group (14.2±7.2 vs. 9.1±4.1μU/mL, p<0.001, and 3.1±1.8 vs. 2.3±1.1, p=0.01 respectively). VFA was similar in patients with PCOS and in the control group. Conclusions. Obese women with PCOS have no preponderant accumulation of visceral fat, compared with weight/age-matched controls. Our data suggest that the distribution of fat to visceral depots is unlikely to be the entire explanation for the metabolic abnormalities observed in women with PCOS.


1995 ◽  
Vol 86 (4) ◽  
pp. 516-519 ◽  
Author(s):  
T DOUCHI ◽  
H HUIN ◽  
S NAKAMURA ◽  
T OKI ◽  
S YAMAMOTO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document